|
|
Volumn 18, Issue 9, 2012, Pages 1314-
|
|
Exon-skipping drug pulls ahead in muscular dystrophy field
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
DRISAPERSEN;
DYSTROPHIN;
ETEPLIRSEN;
PLACEBO;
AVI-4658;
OLIGONUCLEOTIDE;
CLINICAL TRIAL;
DRUG SAFETY;
DRUG TOLERABILITY;
DUCHENNE MUSCULAR DYSTROPHY;
EXON;
GENETIC DISORDER;
HUMAN;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
BIOSYNTHESIS;
CHILD;
CLINICAL TRIAL (TOPIC);
GENETICS;
MALE;
METHODOLOGY;
CHILD;
CLINICAL TRIALS AS TOPIC;
DYSTROPHIN;
EXONS;
HUMANS;
MALE;
MUSCULAR DYSTROPHY, DUCHENNE;
OLIGONUCLEOTIDES;
|
|
EID: 84868658343
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0912-1314 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
